8
Clinical Trials associated with H5N1 influenza vaccine(Sinovac Biotech Ltd.)A Double-blind, Randomized, Stratified and Controlled Clinical Trial With Split-virion and Whole-virion, Adjuvanted and Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
A single center, stratified, randomized and double-blind phase IV clinical trial is to be conducted in healthy elders (equal to or more than 61 years), adults (18-60 years), adolescents (12-17 years) and children (3-11 years) to evaluate the safety and immunogenicity of Sinovac's split-virion or whole-virion novel influenza A (H1N1) vaccines.
Phase IV, Open-label Study to Assess the Durability and Cross-immunity of H5N1 influenza vaccine in Healthy Adult Japanese Volunteers - FLU-PPV-S
Start Date01 Aug 2008 |
Sponsor / Collaborator- |
A Phase II, Open, Randomized Study to Assess the Safety and Immunogenicity of Intramuscular KIB-PIA(H5N1 influenza vaccine) in Healthy Children - KIB-PIA03
Start Date14 Apr 2008 |
Sponsor / Collaborator- |
100 Clinical Results associated with H5N1 influenza vaccine(Sinovac Biotech Ltd.)
100 Translational Medicine associated with H5N1 influenza vaccine(Sinovac Biotech Ltd.)
100 Patents (Medical) associated with H5N1 influenza vaccine(Sinovac Biotech Ltd.)
100 Deals associated with H5N1 influenza vaccine(Sinovac Biotech Ltd.)